In addition, Davis et al. (2012) demonstrated that altered function of ORAI1 and TRPC1 led to EGF-induced EMT changes in triple-negative breast cancer cell lines (Davis et al., 2012). The gene discussed is TRPC1; the disease is triple-negative breast carcinoma.